Jennifer K. Moses - Feb 1, 2022 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
CFO
Signature
/s/ James Stillman Hanson, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Feb 1, 2022
Transactions value $
$9,579
Form type
4
Date filed
2/2/2022, 04:20 PM
Previous filing
Jan 5, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Options Exercise $1.24K +333 +0.94% $3.72 35.9K Feb 1, 2022 Direct F1
transaction GTHX Common Stock Options Exercise $8.34K +2K +5.57% $4.17 37.9K Feb 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Option (Right to Buy) Options Exercise $0 -2K -3.33% $0.00 58K Feb 1, 2022 Common Stock 2K $4.17 Direct F3
transaction GTHX Stock Options (Right to Buy) Options Exercise $0 -333 -100% $0.00* 0 Feb 1, 2022 Common Stock 333 $3.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents (i) 15,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
F2 Represents (i) 17,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
F3 All shares underlying this option have vested.